Compare GRDX & WKHS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GRDX | WKHS |
|---|---|---|
| Founded | N/A | 2007 |
| Country | United Kingdom | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Auto Manufacturing |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 28.6M | 31.8M |
| IPO Year | 2016 | 2008 |
| Metric | GRDX | WKHS |
|---|---|---|
| Price | $4.80 | $2.92 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 86.9K | 60.8K |
| Earning Date | 11-18-2026 | 11-09-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 21.95 | ★ 86.92 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $763,173.00 |
| Revenue This Year | N/A | $61.80 |
| Revenue Next Year | N/A | $67.74 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.87 | $0.53 |
| 52 Week High | $6.93 | $11.80 |
| Indicator | GRDX | WKHS |
|---|---|---|
| Relative Strength Index (RSI) | 65.13 | 45.24 |
| Support Level | $4.51 | $2.81 |
| Resistance Level | $5.30 | $3.56 |
| Average True Range (ATR) | 0.46 | 0.13 |
| MACD | 0.11 | 0.00 |
| Stochastic Oscillator | 81.16 | 36.03 |
GridAI Technologies Corp, formerly known as Entero Therapeutics Inc, is a late clinical-stage biopharmaceutical company focused on the development of targeted, non-systemic therapies for gastrointestinal (GI) diseases. The company's programs address unmet needs in GI health and include: latiglutenase, a Phase 3-ready, potentially first-in-class, targeted, oral biotherapeutic for celiac disease; capeserod, a selective 5-HT4 receptor partial agonist for indications including gastroparesis; and adrulipase, a recombinant lipase enzyme designed to enable the digestion of fats and other nutrients in cystic fibrosis and chronic pancreatitis patients with exocrine pancreatic insufficiency.
Workhorse Group Inc is a technology company with a vision to pioneer the transition to zero-emission commercial vehicles. Its focus is to provide sustainable and cost-effective solutions to the commercial transportation sector. It designs and manufactures all-electric vehicles, including the technology that optimizes the way these vehicles operate. It's focused on a core competency of bringing electric delivery vehicle platforms to serve the last-mile delivery market. Its products are marketed under the Workhorse brand.